China Resources Boya Bio-pharmaceutical Group Co.,Ltd

Informe acción SZSE:300294

Capitalización de mercado: CN¥15.8b

China Resources Boya Bio-pharmaceutical GroupLtd Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Xiaoming Liang

Chief Executive Officer (CEO)

CN¥4.0m

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO3.8yrs
Participación del CEOn/a
Permanencia media de la dirección3.3yrs
Promedio de permanencia en la Junta Directiva2.9yrs

Actualizaciones recientes de la dirección

Recent updates

Investors Can Find Comfort In China Resources Boya Bio-pharmaceutical GroupLtd's (SZSE:300294) Earnings Quality

Nov 01
Investors Can Find Comfort In China Resources Boya Bio-pharmaceutical GroupLtd's (SZSE:300294) Earnings Quality

A Look At The Intrinsic Value Of China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294)

Oct 01
A Look At The Intrinsic Value Of China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294)

Market Participants Recognise China Resources Boya Bio-pharmaceutical Group Co.,Ltd's (SZSE:300294) Earnings

Sep 12
Market Participants Recognise China Resources Boya Bio-pharmaceutical Group Co.,Ltd's (SZSE:300294) Earnings

Does China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Have A Healthy Balance Sheet?

Jul 25
Does China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Have A Healthy Balance Sheet?

China Resources Boya Bio-pharmaceutical Group Co.,Ltd's (SZSE:300294) P/E Is On The Mark

Jun 12
China Resources Boya Bio-pharmaceutical Group Co.,Ltd's (SZSE:300294) P/E Is On The Mark

China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Is Increasing Its Dividend To CN¥0.30

Apr 26
China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Is Increasing Its Dividend To CN¥0.30

Is China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Using Too Much Debt?

Apr 22
Is China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Using Too Much Debt?

China Resources Boya Bio-pharmaceutical GroupLtd's (SZSE:300294) Conservative Accounting Might Explain Soft Earnings

Apr 01
China Resources Boya Bio-pharmaceutical GroupLtd's (SZSE:300294) Conservative Accounting Might Explain Soft Earnings

What Does The Future Hold For China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294)? These Analysts Have Been Cutting Their Estimates

Mar 31
What Does The Future Hold For China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294)? These Analysts Have Been Cutting Their Estimates

CEO

Xiaoming Liang (57 yo)

3.8yrs

Permanencia

CN¥4,017,400

Compensación

Mr. Xiaoming Liang serves as Non-Independent Director at Boya Bio-pharmaceutical Group Co., Ltd since February 03, 2021 and also serves as a President. He is a member of the first session of the Biotechnol...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Xiaoming Liang
President & Directorno dataCN¥4.02msin datos
Huacheng Liang
VP, CFO2.9yrsCN¥1.69msin datos
Bing Chen
Vice President3.8yrsCN¥6.54m0.014%
CN¥ 2.2m
Shousun Ii
Vice President3.8yrsCN¥2.48msin datos
Shuanhong Zhang
Vice President2.3yrsCN¥1.27msin datos

3.3yrs

Permanencia media

47yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 300294 se considera experimentado (3.3 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Xiaoming Liang
President & Director3.8yrsCN¥4.02msin datos
Huacheng Liang
VP, CFO2.9yrsCN¥1.69msin datos
Shao Shao
Supervisorno datasin datossin datos
Na Tang
Chairman of Supervisory Board2.9yrssin datossin datos
Guiling Tan
Non-Employee Representative Supervisor7.7yrssin datossin datos
Weidong Zhang
Independent Director3.8yrsCN¥200.00ksin datos
Huasheng Huang
Independent Director3.8yrsCN¥200.00ksin datos
Li Zhao
Independent Director3.8yrsCN¥200.00ksin datos
Kai Qiu
Chairman of the Board1.1yrssin datossin datos
Jinfeng Shen
Director1.1yrssin datossin datos
Jinni Sun
Directorless than a yearsin datossin datos
Yuxuan Pan
Directorless than a yearsin datossin datos

2.9yrs

Permanencia media

54yo

Promedio de edad

Junta con experiencia: La junta directiva de 300294 no se considera experimentada (2.9 años de permanencia promedio), lo que sugiere una nueva junta directiva.